Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$11.2MFederal grants as PI13 awards
1Patents grantedLatest Oct 3, 2023
21Papers919 citations
Federal awards and patents by year
AwardsPatents
13 awards · $11.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 1, 2023 | NIH | SBIR Phase II Commercialization of methods and reagents for high-throughput single cell analysis | $1.1M | FLUENT BIOSCIENCES INC |
| Aug 29, 2023 | NIH | SBIR Phase II Commercialization of methods and reagents for high-throughput single cell analysis | $1.1M | FLUENT BIOSCIENCES INC |
| Feb 28, 2023 | NIH | SBIR Phase II New tools for highly accessible single cell RNA sequencing | $775K | FLUENT BIOSCIENCES INC |
| Mar 1, 2022 | NIH | SBIR Phase II New tools for highly accessible single cell RNA sequencing | $1.7M | FLUENT BIOSCIENCES INC |
| Feb 25, 2022 | NIH | SBIR Phase II New tools for highly accessible single cell RNA sequencing | $904K | FLUENT BIOSCIENCES INC |
| Aug 31, 2021 | NIH | SBIR Phase II Custom assays for personalized, longitudinal monitoring of circulating tumor DNA using PIPSenSeq | $826K | FLUENT BIOSCIENCES INC |
| Sep 4, 2020 | NIH | SBIR Phase II Custom assays for personalized, longitudinal monitoring of circulating tumor DNA using PIPSenSeq | $1.9M | FLUENT BIOSCIENCES INC |
| Sep 4, 2020 | NIH | SBIR Phase II Custom assays for personalized, longitudinal monitoring of circulating tumor DNA using PIPSenSeq | $1.1M | FLUENT BIOSCIENCES INC |
| Aug 1, 2020 | NIH | SBIR Phase I PIPsceq: powering single cell RNA sequencing into the million cell era | $399K | FLUENT BIOSCIENCES INC |
| Jul 29, 2020 | NIH | SBIR Phase I PIPsceq: powering single cell RNA sequencing into the million cell era | $399K | FLUENT BIOSCIENCES INC |
| Sep 16, 2019 | NIH | SBIR Phase I Anti-cancer drug screening enabled by Pre-templated Instant Partitions and single cell RNA sequencing | $288K | FLUENT BIOSCIENCES INC |
| Sep 16, 2019 | NIH | SBIR Phase I Anti-cancer drug screening enabled by Pre-templated Instant Partitions and single cell RNA sequencing | $288K | FLUENT BIOSCIENCES INC |
| Jul 5, 2019 | NIH | SBIR Phase II Custom assays for personalized, longitudinal monitoring of circulating tumor DNA using PIPSenSeq | $299K | FLUENT BIOSCIENCES INC |
2 patents as inventor
- US 11773452FLUENT BIOSCIENCES INCOct 3, 2023
- US FLUENT BIOSCIENCES INC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#50
Awards as PI#72
Patents#155
Companies
- FLUENT BIOSCIENCES INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.